Congress orders FDA to study microplastics in food and water
H.R. 4486 — Microplastics Safety Act · Filed by Janelle Bynum (D-OR) · 27 cosponsors · Introduced Jul 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the FDA to study how microplastics in food and water affect human health—focusing on children, hormones, cancer, chronic disease, and reproduction—and report findings and policy recommendations to Congress within one year. It creates no new regulations or restrictions; it is a fact-finding mandate.
Why we flagged it
The bill's sole operative mechanism is a directive to the FDA to conduct a study and report on microplastics health impacts. It is a fact-finding and transparency measure, not a regulatory or appropriations action.
What the text implies
- Study findings may trigger future FDA rulemaking on microplastics limits in food/water, potentially affecting food manufacturers, water utilities, and packaging industries.
- One-year deadline is tight for comprehensive study; FDA may rely on existing literature rather than new primary research, limiting novelty of findings.
- Report recommendations could range from voluntary industry standards to mandatory labeling or contamination limits, creating regulatory uncertainty for affected sectors.
- Study scope (children, endocrine, cancer, chronic illness, reproductive health) signals congressional concern about vulnerable populations and systemic health effects, not isolated risk.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens gain access to independent scientific evidence on a potential public health hazard (microplastics in food/water) that currently lacks comprehensive federal study. The report and recommendations may inform future protective regulations, and transparency itself strengthens democratic accountability. No direct costs to citizens are imposed.
Named in the bill
FDA (Food and Drug Administration), HHS (Department of Health and Human Services), Congress, microplastics, food and water supply
Where it stands
27 cosponsors: 14 Republicans, 13 Democrats.
- Jul 17, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jul 17, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
5 lobbying clients named this bill on 7 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,673,000 in lobbying spend. A filing names 30 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 78% of bills with at least one filing.
Janelle Bynum, the sponsor, reported $1,211,198 in PAC receipts in the 2026 cycle.
- Lyondell Chemical Company — $690,000 on 1 filing
- Ocean Conservancy — $403,000 on 2 filings
- Oceana Inc — $280,000 on 1 filing
- World Wildlife Fund, Inc. — $220,000 on 1 filing
- Flexible Packaging Association — $80,000 on 2 filings
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,095 characters) on Aug 24, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress orders FDA to study microplastics in food and water” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4486 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.